{
  "EGFR": {
    "risk_level": "low",
    "approved_drugs": ["erlotinib", "gefitinib", "osimertinib"],
    "known_toxicities": ["skin_rash", "diarrhea"],
    "tissue_specificity": 0.7
  },
  "ERBB2": {
    "risk_level": "low",
    "approved_drugs": ["trastuzumab", "pertuzumab"],
    "known_toxicities": ["cardiotoxicity"],
    "tissue_specificity": 0.8
  },
  "MET": {
    "risk_level": "moderate",
    "approved_drugs": ["capmatinib"],
    "known_toxicities": ["edema", "nausea"],
    "tissue_specificity": 0.5
  }
}

